Pharmaceuticals, Biotechnology and Life Sciences
Ipsen Q1 2019 sales growth of 17.0% as reported, or 15.8%1at constant exchange rates and consolidation scope.
Dr. Mark Erlander, Chief Scientific Officer of Trovagene. “We believe the positive results of our preclinical study provides the scientific rationale for clinical investigation of this combination regimen and may lead to a new treatment option for these patients.”
Pfizer and Eli lilly have announced top-line results from a Phase 3 study evaluating tanezumab 2.5mg and 5 mg.
Winther trial shows RNA profiling togetherwith DNA testing matches more patients with advanced cancer topersonalized therapies than DNA profiling for tumor mutations alone.
Daniel Soland has been appointed to Kalvista Board of Directors .
The global anticoagulants reversal drugs market expected to expand at aCAGR of 15.3% from 2018 to 2026, owing to the approval of blockbusterdrugs in recent years and strong pipeline driving the market.
DUBLIN–(BUSINESS WIRE)–The “Anterior Uveitis – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report offers comprehensive…
DUBLIN–(BUSINESS WIRE)–The “Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering.…
DUBLIN–(BUSINESS WIRE)–The “Specialty Generics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024” report has been added to…
DUBLIN–(BUSINESS WIRE)–The “Drugs of Abuse Testing: Technologies and Global Markets” report has been added to ResearchAndMarkets.com’s offering. Report Scope An…